Skip to main content
. 2025 Sep 19;14(18):6613. doi: 10.3390/jcm14186613
AD anxiety disorders
BBB blood–brain barrier
BDNF
CTIS
brain-derived neurotrophic factor
Clinical Trials Information System
CTA Clinical Trial Application
DMN Default Mode Network
DMT N,N-Dimethyltryptamine
EMA European Medicines Agency
EU European Union
EU CTR EU Clinical Trials Register
EUDA European Union Drugs Agency
FDA Food and Drug Administration
IRB Institutional Review Board
LSD lysergic acid diethylamide
MAPS Multidisciplinary Association for Psychedelic Studies
MD major depression
MDMA 3,4-methylenedioxy-N-methylamphetamine
OCD obsessive-compulsive disorders
PAREA Psychedelics Access and Research European Alliance
PTSD post-traumatic stress disorder
RDD recurrent depressive disorder
TRD treatment-resistant major depression
USA/US United States of America
WHO World Health Organisation